Pharmacology · Dopamine agonists
Pramipexole !
A non-ergot dopamine agonist for Parkinson disease and restless legs. Known for sudden sleep attacks and impulse-control disorders.
Updated 2026-11-01
The figure shows pramipexole bound to the human D3 receptor coupled to its Gi protein.
Mechanism of action
Pramipexole stimulates D2-family dopamine receptors directly, with higher affinity for D3 than for D2 or D4. Because it acts on the receptor, it works even when few dopamine neurons remain.
- Pramipexole binds D3 and D2 receptors in the striatum
- It mimics dopamine without needing dopamine neurons
- Movement circuits are activated again
- Slowness and rigidity improve; restless legs settle
Pharmacokinetics
- Absorption
- Rapidly absorbed; oral bioavailability above 90%
- Elimination
- About 90% recovered in urine, almost all unchanged; the dose is adjusted in kidney disease
- Half-life
- About 8 hours in young adults and about 12 hours in older adults
Indications
- Parkinson disease, alone or with levodopa Parkinson disease →
- Moderate to severe primary restless legs syndrome Restless legs syndrome →
Adverse effects
Common
- Nausea, dizziness, somnolence
- Dyskinesia when added to levodopa
- Orthostatic hypotension, mainly when the dose is raised
- Dry mouth and leg swelling
Contraindications
- No absolute contraindications on the label; caution in kidney disease, psychosis and in people who drive
Key interactions
- Antipsychotics, metoclopramide
- Dopamine antagonists reduce its effect
- Cimetidine and other drugs secreted by the kidney
- Raise pramipexole levels and sleepiness
- Alcohol and sedatives
- More somnolence and sleep attacks
What is monitored
- Daytime sleepiness and episodes of falling asleep
- New gambling, sexual, spending or eating urges (ask the family too)
- Standing blood pressure
- Kidney function
Administration and safety
- Increased gradually and, when stopped, tapered rather than stopped suddenly
- Immediate-release and extended-release tablets are different products
- Taking it with food can reduce nausea
Nursing care
- Teach not to drive until sleepiness is known, and to report sudden sleep
- Ask patient and family about gambling, shopping or sexual behaviour changes
- Check orthostatic blood pressure and fall risk
- Report hallucinations or confusion
Pregnancy and breastfeeding
Animal studies suggest possible harm to the fetus; there are no adequate human data.
Test yourself
Think of the answer, then tap the question to see it.
Which dopamine receptor subtype does pramipexole bind with highest affinity?
D3, more than D2 or D4.
How is pramipexole mainly eliminated?
Unchanged in the urine, so the dose is adjusted in kidney disease.
Which two adverse effects of pramipexole matter for driving and for family finances?
Sudden sleep attacks and impulse-control disorders such as pathological gambling or compulsive spending.
Besides Parkinson disease, which disorder is pramipexole approved for?
Moderate to severe primary restless legs syndrome.
Related drugs
Related conditions
← Back to the class: Dopamine agonists
Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.
Sources: DailyMed - PRAMIPEXOLE DIHYDROCHLORIDE tablet (DailyMed (U.S. National Library of Medicine), 2026); Pramipexole: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2022); Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed., ch. 21 (McGraw Hill, 2023).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.